These studies have shown that AD progresses from asymptomatic stages though MCI to moderate and severe dementia stages, which are associated with specific biomarkers, including elevated levels of EVs containing tau, p-tau-181, and p-tau-231. The gene discussed is MAPT; the disease is Alzheimer disease.